On September 1, Elbit Systems (NASDAQ:ESLT) said it signed contracts worth roughly $270 million with an international customer for advanced ISR and targeting payloads, spanning up to six years of work. It’s the kind of deal that barely moves the needle against a $32 billion order backlog, and that’s exactly the point. Elbit keeps landing these contracts one after another, and each one adds another data point to a growth story that’s been building for years.
The Funnel Keeps Filling Up
The new contracts call for Elbit’s SPECTRO family of multi-spectral electro-optic systems, which combine mid-wave infrared, visible, and short-wave infrared imaging with laser designation and AI-based analytics. The company will also supply AMPS NG systems, built for long-range airborne surveillance and targeting with precise geolocation. Both product lines work day or night and in bad weather, and both are designed to plug into airborne, naval and ground platforms. CEO Bezhalel Machlis called Elbit “a global leader in the field of ISR & Targeting solutions,” and the new deal reinforces that positioning with an international buyer willing to commit to a multi-year program.
That single contract sits on top of a much bigger trend. Elbit’s second-quarter revenue climbed to $2.29 billion from $1.97 billion a year earlier, and adjusted earnings per share rose to $4.14 from $3.23. About 73% of the company’s $32 billion order backlog now comes from outside Israel, with Europe doing much of the heavy lifting as regional defense budgets expand. Machlis has pointed to international markets, particularly the US, Europe, and Asia Pacific, as the main driver, along with strong demand from Abraham Accords countries like the United Arab Emirates. The company is also funding new products, including a helicopter-mounted laser defense system nearing operational status and a ground-based laser interceptor being developed with Rafael, alongside a $1.00 quarterly dividend.
Six-Year Bets Carry Their Own Risk
The flip side is that Elbit’s growth is closely tied to an unusually turbulent moment. The company’s own results note they come nearly three years after the October 7, 2023, Hamas attack on Israel, followed by two years of war in Gaza and separate conflicts with Hezbollah and Iran. Machlis has framed that operational experience as a selling point, but it also means a meaningful share of demand is linked to conflict conditions that could eventually ease. There’s execution risk too. The new $270 million contract runs for up to six years, and Elbit’s own disclosures flag long-term fixed-price contracts, shifting government budget priorities and regulatory approvals as factors that could affect how those numbers actually play out. A backlog is only as good as the company’s ability to deliver against it on schedule.
Funds Pull Back While Shorts Stay Away
Hedge fund ownership of Elbit slipped from 27 funds to 24 in the most recent quarter, a modest pullback rather than an exodus. Short interest, meanwhile, sits at just 0.55% of the float, which signals almost no organized bet against the stock. That combination is a bit of a mixed signal. It suggests that skepticism here is limited to trimming positions rather than outright doubt about the business.
What Happens After The Backlog Fills Up
Elbit’s story right now is straightforward: contracts keep coming in, revenue and earnings keep climbing, and the backlog keeps growing on the back of international demand. The $270 million ISR deal announced on September 1, is just the latest example of that pattern. For the growth to keep compounding, defense budgets in Europe and among Abraham Accords partners need to stay elevated, and Elbit needs to execute cleanly on multi-year, fixed-price work.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Disclosure: None. Follow Insider Monkey on Google News.
